Form 8-K - Current report:
SEC Accession No. 0001558370-25-001051
Filing Date
2025-02-18
Accepted
2025-02-18 07:00:28
Documents
13
Period of Report
2025-02-14
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K bpth-20250214x8k.htm   iXBRL 8-K 37310
  Complete submission text file 0001558370-25-001051.txt   157549

Data Files

Seq Description Document Type Size
2 EX-101.SCH bpth-20250214.xsd EX-101.SCH 3290
3 EX-101.LAB bpth-20250214_lab.xml EX-101.LAB 15928
4 EX-101.PRE bpth-20250214_pre.xml EX-101.PRE 10128
15 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20250214x8k_htm.xml XML 4867
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS, INC. (Filer) CIK: 0001133818 (see all company filings)

EIN.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 25632695
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)